These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34163475)

  • 1. Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4
    Martins CP; New LA; O'Connor EC; Previte DM; Cargill KR; Tse IL; Sims-Lucas S; Piganelli JD
    Front Immunol; 2021; 12():669456. PubMed ID: 34163475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.
    Vazquez-Mateo C; Collins J; Fleury M; Dooms H
    BMC Immunol; 2017 Mar; 18(1):18. PubMed ID: 28356069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.
    Previte DM; O'Connor EC; Novak EA; Martins CP; Mollen KP; Piganelli JD
    PLoS One; 2017; 12(4):e0175549. PubMed ID: 28426686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Glycolysis Suppresses Cell Proliferation and Tumor Progression In Vivo: Perspectives for Chronotherapy.
    Horváthová J; Moravčík R; Matúšková M; Šišovský V; Boháč A; Zeman M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss.
    Wang J; Guan H; Liu H; Lei Z; Kang H; Guo Q; Dong Y; Liu H; Sun Y; Fang Z; Li F
    J Cell Mol Med; 2020 Feb; 24(3):2294-2307. PubMed ID: 31880389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells.
    Berry G; Waldner H
    J Vis Exp; 2013 May; (75):e50389. PubMed ID: 23685789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis.
    Zou Y; Zeng S; Huang M; Qiu Q; Xiao Y; Shi M; Zhan Z; Liang L; Yang X; Xu H
    Br J Pharmacol; 2017 May; 174(9):893-908. PubMed ID: 28239846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
    Pauken KE; Jenkins MK; Azuma M; Fife BT
    Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
    Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
    J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells.
    Yi Z; Li L; Garland A; He Q; Wang H; Katz JD; Tisch R; Wang B
    Eur J Immunol; 2012 Aug; 42(8):2010-8. PubMed ID: 22865049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
    Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
    J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
    Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
    Front Immunol; 2020; 11():576743. PubMed ID: 33519801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma.
    Matsumoto K; Noda T; Kobayashi S; Sakano Y; Yokota Y; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Eguchi H
    Cancer Lett; 2021 Mar; 500():29-40. PubMed ID: 33307155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D supplementation induces CatG-mediated CD4
    Lai X; Liu X; Cai X; Zou F
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.